Home

Celgene Corporation and its employees are working relentlessly to provide solutions for unmet medical needs in cancer and debilitating inflammatory diseases.

There are more than 200 ongoing clinical trials at major medical centres worldwide using innovative compounds from Celgene. These investigational compounds are being actively studied in clinical trials for patients with incurable haematological and solid tumour cancers, including:

multiple myeloma
myelodysplastic syndromes
chronic lymphocytic leukaemia
non-Hodgkin's lymphoma
glioblastoma
ovarian cancer
pancreatic cancer
prostate cancer

By utilising the latest advances in molecular and cellular research to develop novel therapies that target the mechanisms of disease at their source, Celgene is making potentially life-saving treatments a reality for the millions of patients around the world fighting cancer and other debilitating diseases.

Explore: Who we are Our Corporate History or Contact Us

indicates downloadable document in PDF format - get Adobe^® Reader^® here.

This site is intended for persons located in the United Kingdom. Click on the following links to be redirected to other Celgene websites:

Celgene Global: http://www.celgene.com/

Celgene Asia: http://www.celgene.asia/

Celgene Australia: http://www.celgene.com.au/

Celgene Europe: http://www.celgene.eu/

Celgene France: http://www.celgene.fr/

Celgene Germany: http://www.celgene.de/

Celgene Ireland: http://www.celgene.ie

Celgene Italy: http://www.celgene.it

Celgene Japan: http://www.celgene.co.jp

Celgene Spain: http://www.celgene.es